A two-centre open-label non-inferiority trial to assess the immunogenicity and safety of an intradermal and an intra muscular single-visit dosing regimen of purified chick- embryo cell-culture rabies vaccine in adults

    Project Details

    AcronymSINGLE-R
    StatusActive
    Effective start/end date13/02/23 → 31/12/25

    Funding

    • Ministerie van Landsverdediging: €84,500.00